Kling Biotherapeutics
PrivateLast Round
Seed
Jan 1, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Kling Biotherapeutics operates in Healthcare & Life Sciences and is based in Amsterdam. Its latest recorded funding round was a Seed round in January 2021.
Kling Biotherapeutics is a biotechnology company that discovers and develops antibody-based therapeutics for cancer and infectious diseases using its proprietary B-cell immortalization technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kling Biotherapeutics Comparables
Compare Kling Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HiFiBiO | 82% | |
| 株式会社イーベック | 75% | |
| Resonant Therapeutics | 74% |
For institutional investors. Book with your work email.
Kling Biotherapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Kling Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Time BioVentures | Seed |
| UvA Ventures Holding BV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 34% MoM, reaching 2.4K.
- Jun 21, 2026
Monthly visitors grew 109% MoM, reaching 1.8K.
For institutional investors. Book with your work email.
Kling Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kling Biotherapeutics's valuation, stock price, and market status.
Is Kling Biotherapeutics a public or private company?
Kling Biotherapeutics is a private company.
What is the current stock price of Kling Biotherapeutics?
Kling Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Kling Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kling Biotherapeutics worth (valuation)?
Valuation information for Kling Biotherapeutics is not publicly available.
Can I buy Kling Biotherapeutics stock?
Kling Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kling Biotherapeutics's last funding round?
Kling Biotherapeutics's most recent funding round was Seed on January 1, 2021.
Who are the main investors in Kling Biotherapeutics?
Key investors in Kling Biotherapeutics include Time BioVentures.
Will Kling Biotherapeutics IPO soon?
No public IPO plans have been announced for Kling Biotherapeutics.
How can I track Kling Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Kling Biotherapeutics's shares on secondary markets.